Brief: Neurovive Enters Commercial Partnership With Oroboros Instruments
Feb 21 (Reuters) - NeuroVive Pharmaceutical AB NVP.ST :
* NEUROVIVE ENTERS COMMERCIAL PARTNERSHIP WITH OROBOROS
INSTRUMENTS ON MITOCHONDRIAL MEDICINE RESEARCH COMPOUNDS
* SAYS DEPENDING ON BULK QUANTITIES SUPPLIED, AGREEMENT HAS
POTENTIAL TO GENERATE REVENUE TO NEUROVIVE IN RANGE OF EUR
10,000-50,000 PER ANNUM
Source text for Eikon: ID:nWkr4VZlTP
Further company coverage: NVP.ST
(Gdynia Newsroom)
((gdynia.newsroom@thomsonreuters.com; +48 58 772 0920;))